Cargando…
In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013
BACKGROUND: Artemisinin-based combination therapy (ACT) is the recommended first-line treatment of falciparum malaria in all endemic countries. Artemisinin resistance in Plasmodium falciparum has been confirmed in the Greater Mekong subregion (GMS). Dihydroartemisinin-piperaquine (DAPQ) is the most...
Autores principales: | Liu, Hui, Yang, Heng-lin, Tang, Lin-hua, Li, Xing-liang, Huang, Fang, Wang, Jia-zhi, Li, Chun-fu, Wang, Heng-ye, Nie, Ren-hua, Guo, Xiang-rui, Lin, Ying-xue, Li, Mei, Wang, Jian, Xu, Jian-wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333884/ https://www.ncbi.nlm.nih.gov/pubmed/25652213 http://dx.doi.org/10.1186/s12936-015-0584-8 |
Ejemplares similares
-
Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008–2013
por: Liu, Hui, et al.
Publicado: (2014) -
Malaria control along China-Myanmar Border during 2007–2013: an integrated impact evaluation
por: Xu, Jian-Wei, et al.
Publicado: (2016) -
High Antimalarial Efficacy of Dihydroartemisinin–Piperaquine on the China–Myanmar Border: The Calm before the Storm
por: Fairhurst, Rick M.
Publicado: (2015) -
Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China–Myanmar, Thailand–Myanmar, and Thailand–Cambodia borders
por: Ye, Run, et al.
Publicado: (2022) -
Clinical Malaria along the China–Myanmar Border, Yunnan Province, China, January 2011–August 2012
por: Zhou, Guofa, et al.
Publicado: (2014)